September 2026
1. ALYAS JT, Nielsen SF, Buus NH
   Explaining blood pressure reduction heterogeneity in sodium-glucose cotransporter-2 inhibitor trials: a meta-analysis stratified by patient characteristics.
   J Hypertens. 2026;44:1487-1498.
   

   >> Share

   
   July 2026
2. GOVO V, Mateus A, Novela C, Caupers P, et al
   Prevalence of masked hypertension in patients with diabetes: a study in Mozambique.
   J Hypertens. 2026;44:1197-1204.
   

   >> Share

   
   
3. IKONOMIDIS I, Michalopoulou E, Pavlidis G, Nikolaou PE, et al
   Effects of dapagliflozin and dulaglutide on blood pressure and coronary flow in liver steatosis patients with type 2 diabetes.
   J Hypertens. 2026;44:1173-1184.
   

   >> Share

   
   May 2026
4. SIMEUNOVIC A, Brunborg C, Heier M, Berg TJ, et al
   Increased 24-h blood pressure and arterial stiffness in young adults with childhood-onset type 1 diabetes: the Norwegian Atherosclerosis and Childhood Diabetes study.
   J Hypertens. 2026 May 15. doi: 10.1097/HJH.0000000000004338.
   

   >> Share

   
   March 2026
5. ANTZA C, Jordan J, McGowan B, Ciudin A, et al
   Treating obesity and heart failure: a how-to-manage guide from the European Association for the Study of obesity and the European Society of Hypertension working group on diabetes and metabolic risk factors.
   J Hypertens. 2026 Mar 10. doi: 10.1097/HJH.0000000000004285.
   

   >> Share

   
   
6. WANG K, Kroon AA, de Galan BE, Berendschot TTJM, et al
   Associations of blood pressure with retinal arteriolar narrowing and urinary albumin excretion are modified by prediabetes: the Maastricht study.
   J Hypertens. 2026;44:461-469.
   

   >> Share

   
   February 2026
7. SETJIADI D, Delles C, Kroon AA, Ressink K, et al
   Characterization of participants with a disproportionate degree of hypertension-mediated organ damage: the Maastricht study.
   J Hypertens. 2026 Feb 16. doi: 10.1097/HJH.0000000000004265.
   

   >> Share

   
   
8. IKRAM J, Ali A, Huma S, Shah SW, et al
   Intensive versus routine blood pressure control in patients with type 2 diabetes: a meta-analysis and trial sequential analysis.
   J Hypertens. 2026 Feb 10. doi: 10.1097/HJH.0000000000004267.
   

   >> Share

   
   January 2026
9. RENNA NF, Ramirez EI, Arrupe MF, Ramirez JM, et al
   Ambulatory blood pressure monitoring strengthens the cardiovascular signal of GLP-1RA: a meta-analysis of blood pressure and weight mediation.
   J Hypertens. 2026;44:123-129.
   

   >> Share

   
   December 2025
10. GILL E, Jin X, Fernandez C, Urbina EM, et al
    Association of hypertension disorders of pregnancy and left ventricular remodeling after 15 years follow-up: findings from the Bogalusa Heart Study.
    J Hypertens. 2025 Dec 18. doi: 10.1097/HJH.0000000000004216.
    

    >> Share

    
    
11. ROSTAMIAN S, Kaura A, Ariti C, Gupta A, et al
    The impact of blood pressure variability on cardiovascular and renal outcomes in patients with and without diabetes: insights from the Anglo-Scandinavian Cardiac Outcomes Trial.
    J Hypertens. 2025;43:2033-2041.
    

    >> Share

    
    
12. PASDAR Z, Chandanani M, Dhillon N, Carter B, et al
    Hypertensive disorders of pregnancy increase the risk of future ophthalmic disorders: a systematic review and meta-analysis.
    J Hypertens. 2025;43:1903-1911.
    

    >> Share

    
    
13. OKORO C, van der Kallen CJH, Mokhtar SBA, Zhou TL, et al
    Arterial stiffness is associated with small and large fiber neuropathy: The Maastricht Study.
    J Hypertens. 2025;43:1945-1952.
    

    >> Share

    
    November 2025
14. LI X, Yang A, Liu X, Xu S, et al
    Screening of the key single nucleotide polymorphisms in type 2 diabetes mellitus complicated with lower extremity arterial disease by machine learning.
    J Hypertens. 2025 Nov 7. doi: 10.1097/HJH.0000000000004164.
    

    >> Share

    
    June 2025
15. NIELSEN SF, Duus CL, Buus NH, Bech JN, et al
    The effects of empagliflozin on systemic haemodynamic function: three randomized, placebo-controlled trials.
    J Hypertens. 2025;43:1021-1029.
    

    >> Share

    
    May 2025
16. MINARI TP, de Rosso VV, Manzano CF, Humsi MJ, et al
    Correlation of the Mediterranean-Dietary Approaches to Stop Hypertension diet vs. ultra-processed diet with health outcomes in type 2 diabetes and hypertension: new insights from a 12-month interventional study.
    J Hypertens. 2025 May 21. doi: 10.1097/HJH.0000000000004061.
    

    >> Share

    
    
17. HU L, Li J, Wang W, Li Y, et al
    Hypertension accelerates the development of a diabetic nephropathy model with more relevant clinical features in Dahl salt-sensitive rat.
    J Hypertens. 2025 May 2. doi: 10.1097/HJH.0000000000004038.
    

    >> Share

    
    April 2025
18. LIN RT, Gao JW, Yang YC, Chen XW, et al
    Optimizing benefits of intensive SBP control in type 2 diabetes: the crucial role of angiotensin-converting enzyme inhibitors/angiotensin-II type 2 receptor blockers.
    J Hypertens. 2025 Apr 22. doi: 10.1097/HJH.0000000000004037.
    

    >> Share

    
    February 2025
19. WONG HJ, Toh KZX, Teo YH, Teo YN, et al
    Effects of glucagon-like peptide-1 receptor agonists on blood pressure in overweight or obese patients: a meta-analysis of randomized controlled trials.
    J Hypertens. 2025;43:290-300.
    

    >> Share

    
    December 2024
20. KIM JH, Oh S, Hong SJ, Yu CW, et al
    Minimum number of readings necessary for determining long-term visit-to-visit blood pressure variability to predict cardiovascular outcomes in people with diabetes.
    J Hypertens. 2024 Dec 18. doi: 10.1097/HJH.0000000000003954.
    

    >> Share

    
    
21. TU Q, Hyun K, Lin S, Hafiz N, et al
    Impacts of hypertension and diabetes on the incidence of cardiovascular diseases and all-cause mortality: findings from the China Health and Retirement Longitudinal Study cohort.
    J Hypertens. 2024 Dec 12. doi: 10.1097/HJH.0000000000003946.
    

    >> Share

    
    September 2024
22. COTTRELL EC
    Commentary on: 'Finger pulse plethysmography predicts gestational hypertension, preeclampsia and gestational diabetes'.
    J Hypertens. 2024;42:1523-1524.
    

    >> Share

    
    
23. SHU TT, Gao ZX, Mao ZH, Yang YY, et al
    Defective natriuresis contributes to hyperkalemia in db/db mice during potassium supplementation.
    J Hypertens. 2024;42:1632-1640.
    

    >> Share

    
    August 2024
24. WANG N, Chalmers J, Harris K, Poulter N, et al
    Combination blood pressure lowering therapy in patients with type 2 diabetes: messages from the ADVANCE trial.
    J Hypertens. 2024 Aug 27. doi: 10.1097/HJH.0000000000003855.
    

    >> Share

    
    
25. COTE N, Fortier C, Jafari K, Pare M, et al
    Estimated versus measured aortic stiffness: implications of diabetes, chronic kidney disease, sex and height.
    J Hypertens. 2024 Aug 26. doi: 10.1097/HJH.0000000000003845.
    

    >> Share

    
    May 2024
26. SHAHRBABAKI SS, Liu X, Baumert M
    Finger pulse plethysmography predicts gestational hypertension, preeclampsia and gestational diabetes.
    J Hypertens. 2024 May 15. doi: 10.1097/HJH.0000000000003775.
    

    >> Share

    
    April 2024
27. SASAKI N, Maeda R, Ozono R, Yoshimura K, et al
    Differences in the impact of newly diagnosed type 2 diabetes on cardiovascular mortality between normotensive and hypertensive individuals.
    J Hypertens. 2024;42:610-619.
    

    >> Share

    
    
28. BARCELLOS PAM, Dall'Agnol A, Sandi GM, Remonti LR, et al
    Dietary approach for the treatment of arterial hypertension in patients with diabetes mellitus.
    J Hypertens. 2024;42:583-593.
    

    >> Share

    
    
29. WANG R, Zhao J, Li L, Huo Y, et al
    Associations between lipid-lowering drugs and pregnancy and perinatal outcomes: a Mendelian randomization study.
    J Hypertens. 2024;42:727-734.
    

    >> Share

    
    March 2024
30. MAVROGEORGIS E, Kondyli M, Mischak H, Vlahou A, et al
    Multiple urinary peptides are associated with hypertension: a link to molecular pathophysiology.
    J Hypertens. 2024 Mar 29. doi: 10.1097/HJH.0000000000003726.
    

    >> Share

    
    February 2024
31. TARKKONEN A, Fickweiler W, Eriksson M, Sun JK, et al
    Retinal artery to vein ratio is associated with cerebral microbleeds in individuals with type 1 diabetes.
    J Hypertens. 2024 Feb 28. doi: 10.1097/HJH.0000000000003690.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share